Drug Overdose Deaths Among Medicaid Beneficiaries Authors: Tami L. Mark, Benjamin D. Huber Published: 2024 ABSTRACT Key PointsQuestionWhat is the rate of drug overdose among Medicaid beneficiaries?FindingsIn this study, in 2020, the drug overdose death rate among Medicaid beneficiaries was 54.6 per 100 000 (44 277 of 91 783 overdose deaths), a rate that was twice as high as the drug overdose rate among all US residents (27.9 per 100 000). For each age and sex group older than 15 years, overdose deaths were higher for the Medicaid population than for the US population, with the greatest difference occurring among adults ages 45 to 64 years, and from 2016 to 2020, Medicaid overdose deaths increased by 54.%.MeaningThe results of this study suggest that drug overdose prevention interventions should be targeted toward Medicaid beneficiaries. Introduction In 2023, an unprecedented number of individuals in the US died of a drug overdose.1 The US overdose rate is much higher than in other high-income countries.2 Drug overdose deaths are a leading cause of injury deaths, and injury deaths are one of the top 5 causes of death in the US.3,4 In 2022, the federal government spent $39.3 billion on reducing drug use and overdose.5 To address the drug overdose epidemic, we must know what populations to prioritize. Population characteristics associated with overdose death include being male, young adulthood, having a disability, certain occupations, unstable housing, incarceration, unemployment, use of certain types of drugs (eg, fentanyl), and living in areas with high poverty and income inequality.6,7,8,9,10,11 Medications for opioid use disorders substantially reduce the risk of overdose death.12 In this study, we determined the rate of drug overdose deaths among Medicaid beneficiaries. Medicaid provides health coverage for millions of low-income adults and children and individuals with disabilities as well as nursing home coverage for low-income adults. To our knowledge, these are the first data published on the rate of overdose deaths among all Medicaid beneficiaries. Methods Data Sources and Description The study was approved by the RTI institutional review board, which provided a waiver of informed consent. We followed the EQUATOR reporting guidelines. We used Medicaid beneficiary enrollment and demographic data from the US Centers for Medicare & Medicaid Service’s (CMS) Transformed Medicaid Statistical Information System (T-MSIS) files and the US Centers for Disease Control and Prevention (CDC) National Death Index (NDI) data for 2016 to 2020. For these years, CMS and CDC created a unique beneficiary identifier that allowed linkage of Medicaid enrollment and NDI data. The NDI data include the death date and the cause of death reported on the death certificates of decedents. The T-MSIS data without the NDI data contained an indicator of whether the Medicaid beneficiary died; however, the cause of death was not indicated, and the death indicator was based on state Medicaid enrollment information, which is not as accurate as the NDI. We identified the cause of death as a drug overdose using International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) codes that the CDC uses (unintentional drug poisoning: X40-X44; suicide by drug poisoning: X60-X64; homicide by drug poisonings: X85; and drug poisoning of undetermined intent: Y10-Y14).13 Overdose Death Rates Using the T-MSIS–linked NDI data, we calculated the number of Medicaid beneficiaries who died each calendar year by age and sex group. The T-MSIS variables (beneficiary identifier, year age, and sex) were determined to be of high quality. To determine the denominator for the overdose death rate, we calculated the number of Medicaid beneficiaries enrolled each year adjusted by the number of months that they were enrolled (eg, a person enrolled for 6 months of the year would be counted as 0.5 person, whereas a person enrolled for 12 months of the year would be counted as 1 person). We divided the total number of overdose deaths each year by the month-weighted enrollment counts. The rates using the unweighted enrollment counts are reported in the eTable in Supplement 1 and do not differ meaningfully from the month adjusted rates. We compared the Medicaid overdose death rates by age group and sex with the overdose death rates for the whole US population as reported in the CDC’s WONDER online database.14 Results The 81 071 574 individuals enrolled in Medicaid are more likely to be female and younger than the US population (Table 1). Across all age groups, the Medicaid drug overdose death rate was 2 times the overall US drug overdose death rate (27.9 deaths vs 54.6 overdose deaths per 100 000) (Table 2). In 2020, Medicaid beneficiaries comprised 25% of the US population (81 071 574 of 329 484 123 individuals) but 48% of all overdose deaths (44 277 of 91 783 deaths). The overdose rate was low and equivalent for the age group younger than 15 years. For each age group older than 15 years, overdose deaths were higher for the Medicaid population than for the US population, with the greatest difference occurring among adults ages 45 to 64 years. For individuals ages 15 to 24 years, the rate was 1.2 times higher for Medicaid beneficiaries than the US population (16.7 vs 19.8 per 100 000); for ages 25 to 34 years, it was 1.9 times higher (47.3 vs 90.7 per 100 000); for ages 35 to 44 years, it was 2.4 times higher (53.9 vs 128.7 per 100 000); for ages 45 to 54 years, it was 3.2 times higher (46.9 vs 149.8 per 100 000); for ages 55 to 64 years, it was 3.3 times higher (37.3 vs 124.8 per 100 000); and for individuals ages 65 years and older, it was 2.8 times higher (9.4 vs 26.3 per 100 000). Examining the results by sex within age revealed that Medicaid beneficiaries had higher rates of overdose deaths than the total US population for every age group and sex combination except for female individuals younger than 15 years. Thus, the high rate of Medicaid overdose deaths cannot be explained by differences in the age or sex distribution of the Medicaid population compared with the US population. Table 1. Age and Sex Distributions of US Residents and the Medicaid Population in 2020CharacteristicUS population, % (n = 329 484 123)aMedicaid population, % (n = 81 071 574)bSex Female50.855.4 Male49.244.6Age, y <15 y18.332.8 15-2412.916.5 25-3414.013.3 35-4412.810.5 45-5412.38.1 55-6412.98.7 ≥6516.910.1 a Data from the US Centers for Disease Control and Prevention and National Center for Health Statistics via the National Vital Statistics System mortality data from 2018 to 2022 and WONDER Online Database (released in 2024). Data are from the Multiple Cause of Death Files from 2018 to 2022, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. b Authors’ calculations based on US Centers for Medicare & Medicaid Service Transformed Medicaid Statistical Information System enrollment data and adjusted for months of enrollment. Age and Sex Distributions of US Residents and the Medicaid Population in 2020 Data from the US Centers for Disease Control and Prevention and National Center for Health Statistics via the National Vital Statistics System mortality data from 2018 to 2022 and WONDER Online Database (released in 2024). Data are from the Multiple Cause of Death Files from 2018 to 2022, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. Authors’ calculations based on US Centers for Medicare & Medicaid Service Transformed Medicaid Statistical Information System enrollment data and adjusted for months of enrollment. Table 2. Overdose Deaths Among US Residents and Medicaid Beneficiaries by Selected Age and Sex Groups in 2020Age group, yUS population, No.aMedicaid population, No.bRatiocResidents2020 Overdose deathsOverdose deaths per 100 000No. of full-year equivalent Medicaid beneficiariesd2020 Overdose deathsOverdose deaths per 100 000All ages329 484 12391 78327.981 071 57444 27754.62.0 Female167 227 92128 06916.844 940 02615 48434.52.1 Male162 256 20263 71439.336 125 73428 79279.72.0<1560 293 4262470.426 589 4311160.41.0 Female29 490 5481250.412 953 298540.41.0 Male30 802 8761220.413 632 833620.51.315-2442 555 684709516.713 404 608265419.81.2 Female20 828 24119909.67 277 65495213.11.4 Male21 727 443510523.56 126 849170227.81.225-3446 069 64621 78447.310 770 532976990.71.9 Female22 625 267614127.16 924 416350650.61.9 Male23 444 37915 64366.73 846 0606263162.82.435-4442 136 19222 71053.98 504 16110 947128.72.4 Female21 090 324679132.25 165 730388775.22.3 Male21 045 86815 91975.63 338 3347060211.52.845-5440 366 13318 91946.96 551 6179817149.83.2 Female20 441 441608929.83 634 440345895.13.2 Male19 924 69212 83064.42 916 8576358218.03.455-6442 403 67715 81937.37 063 4118817124.83.3 Female21 914 243509623.33 787 979293277.43.3 Male20 489 43410 72352.33 274 6595885179.73.4≥6555 659 36552099.48 187 814215726.32.8 Female30 837 85718375.65 196 50969513.42.4 Male24 821 508337213.62 990 143146248.93.6 a Data from the US Centers for Disease Control and Prevention and National Center for Health Statistics via the National Vital Statistics System mortality data from 2018 to 2022 and WONDER Online Database (released in 2024). Data are from the Multiple Cause of Death Files from 2018 to 2022, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. b Authors’ calculations based on US Centers for Medicare & Medicaid Service Transformed Medicaid Statistical Information System enrollment data and adjusted for months of enrollment. c This percentage was calculated by dividing the Medicaid overdose rate by the all US overdose rate. d 5814 Transformed Medicaid Statistical Information System records (0.007% of the total number of records) were missing data on sex. All records are included in total estimates, while only records with data on sex are included in the female and male estimates. Overdose Deaths Among US Residents and Medicaid Beneficiaries by Selected Age and Sex Groups in 2020 Data from the US Centers for Disease Control and Prevention and National Center for Health Statistics via the National Vital Statistics System mortality data from 2018 to 2022 and WONDER Online Database (released in 2024). Data are from the Multiple Cause of Death Files from 2018 to 2022, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. Authors’ calculations based on US Centers for Medicare & Medicaid Service Transformed Medicaid Statistical Information System enrollment data and adjusted for months of enrollment. This percentage was calculated by dividing the Medicaid overdose rate by the all US overdose rate. 5814 Transformed Medicaid Statistical Information System records (0.007% of the total number of records) were missing data on sex. All records are included in total estimates, while only records with data on sex are included in the female and male estimates. From 2016 through 2020, the overdose rate among Medicaid beneficiaries increased by 54.2%, from 35.4 deaths to 54.6 deaths per 100 000 (Table 3). Data after 2020 for Medicaid beneficiaries are not available; therefore, we do not know if Medicaid overdose rates continued to rise through 2023 as they did for all overdose deaths. Table 3. Overdose Deaths Among Medicaid Beneficiaries From 2016 to 2020YearNo. of full-year–equivalent Medicaid beneficiariesaYearly overdose deaths among Medicaid beneficiariesOverdose deaths per 100 000 Medicaid 201678 903 64127 93035.4201779 073 19332 59141.2201878 444 50831 62340.3201977 053 35933 06742.9202081 071 57444 27754.6202190 764 383NANAAbbreviation: NA, not applicable. a Authors’ calculations based on US Centers for Medicare & Medicaid Service Transformed Medicaid Statistical Information System enrollment data and adjusted for months of enrollment. Overdose Deaths Among Medicaid Beneficiaries From 2016 to 2020 Abbreviation: NA, not applicable. Authors’ calculations based on US Centers for Medicare & Medicaid Service Transformed Medicaid Statistical Information System enrollment data and adjusted for months of enrollment. Discussion The results of this study suggest that there is an urgent need to reduce drug overdose deaths among Medicaid beneficiaries. Although Congress, federal agencies, and states expanded Medicaid coverage of substance use disorder treatment, coverage gaps remain.15 Moreover, Medicaid laws and regulations largely only allow reimbursement for health care services delivered by Medicaid-participating health professionals to individual Medicaid beneficiaries. Thus, population-based harm reduction and primary prevention interventions, such as the distribution of fentanyl test strips and social marketing campaigns warning about the risk of fentanyl in the illicit drug supply, can only be paid for by more limited state and federal discretionary funding. The Medicaid program can be viewed as a proxy for low-income individuals. The higher risk of drug use and overdose among Medicaid beneficiaries may be associated with the socioeconomic characteristics of Medicaid beneficiaries. Addressing the socioeconomic factors associated with substance use head on maybe more effective in the long term than focusing on preventing and treating substance use. However, more research is needed to understand whether programs and policies associated with improved socioeconomic characteristics are also associated with reduced drug use and associated harms. This study was possible because CDC and CMS linked Medicaid data to NDI data. To our knowledge, CMS and CDC have no immediate plans to continue linking the data. Similarly, most states only link Medicaid and mortality data as a 1-time effort to answer a particular question. Policymakers and researchers need access to ongoing linked data to identify which Medicaid subpopulations are most at risk of drug overdoses and evaluate interventions to reduce drug overdose deaths. Limitations This study did not account for deaths that may have been a consequence of drug use, such as infections, cardiac arrest, injuries, and exposure. Furthermore, to our knowledge, data do not exist to compare Medicaid with the non-Medicaid population. Therefore, we were only able to compare Medicare with the whole US population, which diluted the differences. Finally, the goal of this study was not to unpack why Medicaid is associated with overdose deaths, such as whether it is a proxy for social determinants of health or reflects drug patterns, or treatment receipt. This type of further research is clearly needed. Conclusions This study suggests that drug overdose deaths remain a leading cause of death in the US despite years of investment to try to address the opioid epidemic. Medicaid beneficiaries are at high risk of drug overdoses. Federal and states agencies should invest in timely and accessible linked mortality and Medicaid data to better understand and target interventions toward the populations at highest risk.